Right 2-3months back bottoming out of spreads did happen. FY2027 should be the time DNL can fire on all cylinders given the amount of capex going live.
Just like the promoter, Market might look to price in the inevitable probability much sooner.
Right 2-3months back bottoming out of spreads did happen. FY2027 should be the time DNL can fire on all cylinders given the amount of capex going live.
Just like the promoter, Market might look to price in the inevitable probability much sooner.
The Nifty Bank index closed 1.03 per cent up at 51530.9.
The Nifty Pharma index closed 2.01 per cent down at 23305.15.
TCS Q2 Results: Tata Consultancy Services (TCS), India’s leading software exporter, reported a 5% growth in consolidated net profit, reaching Rs 11,909 crore for Q2 ended September 2024, compared to Rs 11,342 crore in the same period last year. However, this figure fell short of analysts’ expectations, which estimated a profit of Rs 12,450 crore. Revenue from operations rose 8% year-on-year to Rs 64,259 crore.
The 30-share BSE Sensex closed up 144.31 points at 81611.41
Camera maker Nikon jumped 5.6 percent to become the Nikkei’s top percentage gainer.
Leading stock exchange BSE on Thursday acknowledged Ratan Tata’s lasting influence on the nation’s business landscape, saying “India has lost a pioneer, but not his legacy.” In its condolence message on the death of Tata, BSE highlighted the industrialist’s unparalleled contribution to Indian industry, noting that his visionary leadership continues to serve as an inspiration.
Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Paliperidone Extended-Release Tablets, 1.5 mg, 3 mg, 6 mg, and 9 mg (USRLD: Invega Extended-Release Tablets, 1.5 mg, 3 mg, 6 mg, and 9 mg).
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Latest Stock Market News
The Most Valuable Commodity Is Information!